Calamos Advisors’s Imperva, Inc. IMPV Stock Holding History

Calamos Advisors’s Portfolio IMPV Stock Details IMPV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-9,200	Closed	-$623K	–	731
2015 Q2	$623K	Sell	9,200 -3,670	-29%	-$203K	﹤0.01%	579
2015 Q1	$550K	Buy	12,870 +3,400	+36%	+$151K	﹤0.01%	586
2014 Q4	$468K	Buy	+9,470	New	+$379K	﹤0.01%	610
2013 Q4	–	Sell	-9,700	Closed	-$408K	–	660
2013 Q3	$408K	Buy	+9,700	New	+$462K	﹤0.01%	573

Other funds holding IMPV

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Calamos Advisors's IMPV Position: Q3 2015 in Review

Calamos Advisors sold out of Imperva, Inc. (IMPV) in Q3 2015, closing a stake of 9,200 shares — an estimated $623K sold.

Calamos Advisors first reported a position in IMPV in Q3 2013 and held it in 4 quarters. The position peaked at $623K in Q2 2015. 180 funds tracked by Wall St. Rank hold IMPV as of Q3 2015.

Calamos Advisors reported no remaining Imperva, Inc. position as of Q3 2015 after selling out during the quarter.
Calamos Advisors sold 9,200 Imperva, Inc. shares in Q3 2015, an estimated $623K.
Calamos Advisors first reported a position in Imperva, Inc. in Q3 2013 and held it in 4 quarters.
Calamos Advisors's Imperva, Inc. position peaked at $623K in Q2 2015.
180 funds tracked by Wall St. Rank held Imperva, Inc. as of Q3 2015.

Based on Calamos Advisors's 13F filing for Q3 2015, filed 10 Nov 2015.